Nascent Biotech Inc. Annual Net Cash Provided by (Used in) Operating Activities in USD from 2013 to 2023

Taxonomy & unit: us-gaap: USD
Description: Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
Summary: Nascent Biotech Inc. quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from 2013 to 2023.
Nascent Biotech Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending June 30, 2024 was -$325K, a 99.6% decline year-over-year.
Nascent Biotech Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$1.19M, a 33.6% increase from 2022.
Nascent Biotech Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$1.79M, a 532% decline from 2021.
Nascent Biotech Inc. annual Net Cash Provided by (Used in) Operating Activities for 2021 was $413K.

Net Cash Provided by (Used in) Operating Activities, Annual (USD)

Net Cash Provided by (Used in) Operating Activities, YoY Annual Growth (%)

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
2023	-$1.19M	+$601K	+33.6%	Apr 1, 2023	Mar 31, 2024	10-K	2024-07-01
2022	-$1.79M	-$2.2M	-532%	Apr 1, 2022	Mar 31, 2023	10-K	2024-07-01
2021	$413K	+$1.4M		Apr 1, 2021	Mar 31, 2022	10-K/A	2023-07-03
2020	-$987K	-$432K	-78%	Apr 1, 2020	Mar 31, 2021	10-K	2022-06-15
2019	-$554K	+$157K	+22.1%	Apr 1, 2019	Mar 31, 2020	10-K	2021-07-08
2018	-$712K	+$513K	+41.9%	Apr 1, 2018	Mar 31, 2019	10-K	2020-06-22
2017	-$1.22M	-$456K	-59.3%	Apr 1, 2017	Mar 31, 2018	10-K	2019-07-12
2016	-$769K	-$598K	-351%	Apr 1, 2016	Mar 31, 2017	10-K	2018-06-29
2015	-$170K	+$303K	+64%	Apr 1, 2015	Mar 31, 2016	10-K	2017-06-29
2014	-$473K	-$344K	-265%	Apr 1, 2014	Mar 31, 2015	10-K	2016-07-14
2013	-$130K			Apr 1, 2013	Mar 31, 2014	10-K	2015-07-02

* An asterisk sign (*) next to the value indicates that the value is likely invalid.